Millennium Management’s Journey Medical DERM Stock Holding History

Millennium Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.8M	Sell	383,067 -74,745	-16%	-$580K	﹤0.01%	3975
2025 Q4	$3.53M	Buy	+457,812	New	+$3.59M	﹤0.01%	3393
2025 Q2	–	Sell	-21,473	Closed	-$127K	–	5937
2025 Q1	$127K	Buy	+21,473	New	+$106K	﹤0.01%	5398
2024 Q2	–	Sell	-36,117	Closed	-$133K	–	5997
2024 Q1	$133K	Sell	36,117 -38,914	-52%	-$169K	﹤0.01%	5505
2023 Q4	$432K	Buy	75,031 +60,569	+419%	+$270K	﹤0.01%	4728
2023 Q3	$39.6K	Buy	+14,462	New	+$32.3K	﹤0.01%	5527
2022 Q2	–	Sell	-21,449	Closed	-$103K	–	7064
2022 Q1	$103K	Buy	+21,449	New	+$107K	﹤0.01%	6125

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Millennium Management's DERM Position: Q1 2026 in Review

Millennium Management reduced its Journey Medical (DERM) stake by 16% in Q1 2026, selling an estimated $580K and leaving 383,067 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3975.

Millennium Management first reported a position in DERM in Q1 2022 and has held it in 7 quarters since. The position peaked at $3.53M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

Millennium Management held 383,067 shares of Journey Medical worth $1.8M as of Q1 2026.
Millennium Management sold 74,745 Journey Medical shares in Q1 2026, an estimated $580K.
Journey Medical made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3975 holding.
Millennium Management first reported a position in Journey Medical in Q1 2022 and has held it in 7 quarters since.
Millennium Management's Journey Medical position peaked at $3.53M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.